Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease

Allogeneic hematopoietic cell transplantation (allo-HCT), a treatment option in hematologic malignancies and bone marrow failure syndromes, is frequently complicated by Graft-versus-host disease (GVHD). The primary treatment for GVHD involves immune suppression by glucocorticoids. However, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuirk, Joseph P., Smith, J. Robert, Divine, Clint L., Zuniga, Micheal, Weiss, Mark L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491656/
https://www.ncbi.nlm.nih.gov/pubmed/25894816
http://dx.doi.org/10.3390/ph8020196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491656/
https://www.ncbi.nlm.nih.gov/pubmed/25894816
http://dx.doi.org/10.3390/ph8020196

Ejemplares similares